Status:
COMPLETED
Nocebo Effect in OSA Patients With CPAP Treatment
Lead Sponsor:
Hospital Clinic of Barcelona
Conditions:
Obstructive Sleep Apnea
Eligibility:
All Genders
18+ years
Phase:
NA
Brief Summary
This study is aimed to evaluate whether the information provided by health care professionals in the visits previous to start with CPAP treatment may influence the number of reported adverse effects a...
Detailed Description
Background: The presence of side effects in the first few weeks of treatment with CPAP is common. However, it has never been evaluated whether side effects could be related to the presence of the noce...
Eligibility Criteria
Inclusion
- Patients diagnosed with OSA with indication for CPAP treatment
- To be over 18 years old
- Sign informed consent for study participation.
Exclusion
- Patients previously treated with CPAP.
- Patients with other previous treatments for OSA (surgery, mandibular advancement device, etc.)
- Presence of any other previously diagnosed sleep disorder
- Patients with\> 50% central sleep apnea or Cheyne-Stokes respiration
- Diagnosis of a mental or physical condition that makes difficult to complete questionnaires
Key Trial Info
Start Date :
March 8 2022
Trial Type :
INTERVENTIONAL
Allocation :
ACTUAL
End Date :
March 3 2024
Estimated Enrollment :
97 Patients enrolled
Trial Details
Trial ID
NCT05284045
Start Date
March 8 2022
End Date
March 3 2024
Last Update
March 5 2024
Active Locations (1)
Enter a location and click search to find clinical trials sorted by distance.
1
Hospital Clinic Barcelona
Barcelona, Spain, 08036